1 | Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine | [3] Bupivacaine Bupivacaine, Clonidine, Epinephrine | [3] D00095
D00095
,
D00281
(Name: Clonidine),
D07552
| [14] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 70 70 |
2 | Clonidine | [1] Clonidine Clonidine | [1] D00281
D00281
(Name: Clonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [4] 6 6, 65, 70, 78 |
3 | Clonidine HCl CF 0,150 mg, tabletten | [1] Clonidine Clonidine | [1] D00281
D00281
(Name: Clonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 78 78 |
4 | Clonidine hydrochloride | [1] Clonidine Clonidine | [1] D00281
D00281
(Name: Clonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 6 6, 78 |
5 | Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate | [5] Arginine Arginine, Clonidine, Estradiol, Estradiol valerate, Somatotropin | [4] D00105
D00105
,
D00281
(Name: Clonidine),
D01413
,
D02982
| [5] ADRA2A ADRA2A, ADRA2B, ADRA2C, ESR1, ESR2 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 |